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Abstract
Health and psychosocial service needs that may be co-morbid with opioid addiction may impede the
success of drug treatment among patients attending methadone maintenance treatment programs
(MMTPs). This longitudinal panel study investigates whether receipt of services from one or more
helping professionals outside of the MMTP confers a benefit for drug treatment outcomes among a
random sample of male MMTP patients (N = 356). Each participant was interviewed 3 times, with
6 months between each interview. Since this observational study did not employ random assignment,
propensity score matching was employed to strengthen causal validity of effect estimates. Results
support hypotheses that receiving additional off-site services has significant beneficial effects in
increasing the likelihood of abstaining from cocaine, heroin, and any illicit drug use over both the
ensuing 6 month and 12 month time periods. These findings indicate that receipt of additional medical
and/or psychosocial services enhances the efficacy of methadone treatment in increasing abstinence
from illicit drug use.
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1. Introduction
Although lifetime of heroin use in the U.S. appear to have roughly plateaued in recent years
at the highest levels since the 1970s (Substance Abuse and Mental Health Services
Administration, 2003, 2004), past month prevalence rates of heroin use have increased
significantly from 2005 to 2006 (Substance Abuse and Mental Health Services Administration,
2007). Among single categories of illicit drugs, recent data also suggest that past month
prevalence rates of non-prescription use of pain relievers is second only to marijuana use, with
a significant increase from 2005 to 2006 among all pain relievers as well as for the opioid
analgesic OxyContin (Substance Abuse and Mental Health Services Administration, 2007).
According to a recent report (Substance Abuse and Mental Health Services Administration,
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2004), among past year heroin users, the proportion who are dependent is 57.6%, a figure which
is more than twice as high as the estimate for the next highest proportion (27.5% for cocaine).
Studies consistently demonstrate that methadone treatment for opioid abuse is one of the most
effective (Institute of Medicine, 1995; National Consensus Development Panel on Effective
Medical Treatment of Opiate Addiction, 1998) and cost-beneficial means to address opioid
addiction (Barnett & Hui, 2000; Joseph, Stancliff, & Langrod, 2000).
Research with patients attending methadone maintenance treatment programs (MMTPs) has
documented high levels of need with respect to physical health (Aszalos, McDuff, Weintraub,
Montoya, & Schwartz, 1999; Gearing & Schweitzer, 1974; Hagen & Des Jarlais, 2000; Joseph
et al., 2000; Novick, 2000), psychological or mental health (Ball & Ross, 1991; Brooner, King,
Kidorf, Schmidt, & Bigelow, 1997; Calsyn, Wells, Fleming, & Saxon, 2000; Milby et al.,
1996; Schiff, El-Bassel, Engstrom, & Gilbert, 2002), and other psychosocial difficulties (Ball
& Ross, 1991; El-Bassel et al., 2001; El-Bassel, Gilbert, Schilling, & Wada, 2000; Joseph et
al., 2000; Widman, Platt, Lidz, Mathis, & Metzger, 1997). These needs, if unmet, are thought
to be related to continued drug use or relapse (Joe, Simpson, & Sells, 1994; Saxon, Wells,
Fleming, Jackson, & Calsyn, 1996; Wasserman, Korcha, Havassy, & Hall, 1998) and/or
dropout from methadone treatment (Joe, Simpson, & Hubbard, 1991; McLellan, 1983;
Simpson et al., 1997). These propositions appear to be supported by several randomized clinical
trials (RCTs) that have demonstrated beneficial outcomes when health, psychosocial, and/or
behavioral services were provided in conjunction with methadone treatment (McLellan et al.,
1993; Umbricht-Schneiter, Ginn, Pabst, & Bigelow, 1994; Woody et al., 1983; Woody,
McLellan, Luborsky, & O’Brien, 1995). Furthermore, greater provision of psychosocial
support services in MMTPs has been found to be more cost-effective than methadone treatment
alone or with lower levels of support services (Kraft, Rothbard, Hadley, McLellan, & Asch,
1997; Shepard, Larson, & Hoffmann, 1999). Similar findings have been reported among a
wider range of substance abuse treatment venues as well (Broome, Simpson, & Joe, 1999;
Friedmann, Alexander, Jin, & D’Aunno, 1999; J. C. Marsh, Cao, & D’Aunno, 2004; J.C.
Marsh, D’Aunno, & Smith, 2000; McLellan et al., 1998; Smith & Marsh, 2002).
In spite of the demonstrated value of additional services, the provision of additional services
within MMTPs has decreased in recent years (Etheridge, Hubbard, Anderson, Craddock, &
Flynn, 1997), most likely as a result of cost containment and unit cost reduction efforts. To
compensate, the trend has been to refer or rely on off-site service providers. However, the
question of whether receipt of services from service providers outside of the MMTP improves
drug treatment outcomes among methadone clients has not been answered. This study seeks
to examine the effects of receiving additional off-site services among MMTP patients. To this
end, this study tests hypotheses regarding the effect of receiving additional off-site services on
likelihood of subsequently abstaining from illicit drug use among a random sample of men on
methadone. We employed propensity score matching to minimize bias arising from the non-
experimental design of the study.
2. Methods
2.1 Design and study population
Data were collected as part of a longitudinal, panel study (conducted between 1999–2004)
originally designed to examine the relationships among substance abuse, intimate partner
violence, and HIV risks among a random sample of male MMTP patients (see El-Bassel et al.,
2001) for more information about the parent study). Study participants were patients attending
one of seven MMTPs, operating under the same healthcare provider, located in the Harlem
area of New York City (NYC). Of the randomly selected 1,300 men from the list of 2,067 male
patients enrolled in the seven MMTPs; 774 were reached and agreed to completed a 15-minute
screening interview to determine eligibility for the main phase of the study. Eligibility criteria
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for the main phase were: (1) being male aged 18 or over; (2) being enrolled in an MMTP for
at least three months; and (3) during the past year, having had a sexual relationship with a
woman whom the man described as his girlfriend, spouse, regular sexual partner, or the mother
of his children. A total of 356 men met eligibility criteria and agree to participate in the
longitudinal study, which consisted of a 90 minute, face-to-face structured interview conducted
within a week of screening (i.e., “baseline”) and similar follow-up interviews six and twelve
months later. The Institutional Review Boards of the participating MMTPs and Columbia
University (the research institution) approved the protocol for this study, and all participants
provided informed consent prior to each interview.
2.2 Procedures
Interviews were conducted by trained, male research assistants in a private office located in
the MMTP or, if the participant preferred, a private interview room located at the research
institution. Each structured interview elicited self-reported data on the measures described
below. Participants were compensated $5 for completing the screening interview. During the
main phase of the study, participants were given a Metrocard (value = $4) at each interview to
cover the cost of transportation. In addition, participants received $25 upon completion of the
baseline interview, $35 for the 6-month follow-up interview, and $50 for the 12-month follow-
up interview. Retention rates at follow-up were 81% (n = 287) and 79% (n = 280) at 6- and
12-month follow-up timepoints respectively.
2.3 Measures
Sociodemographic data collected included age; race/ethnicity; years of formal education;
current employment status (0 = unemployed; 1 = employed “either on or off the books”);
monthly income; whether the participant had health insurance; and marital status (0 = Single,
never married; 1 = divorced, separated, or widowed; 2 = legally or common-law married).
Other background variables included duration of current methadone treatment and current
methadone dose. Sociodemographic data were collected at screening and baseline.
In addition to the aforementioned sociodemographic variables, analyses described below
included variables that may capture different levels of service needs that, in turn, may
differentially affect receipt of additional services, thus potentially confounding the observed
relationships between receipt of services and outcome variables in an observational (i.e., non-
randomized controlled) study. HIV status was ascertained based on participants’ self-reports.
Using the Stressful Life Events Checklist (SLEC) from the Posttraumatic Stress Diagnostic
Scale(Foa, 1995), participants were asked whether they experienced each of a specific series
of 20 stressors or stressful events prevalent within urban, impoverished communities (e.g.,
serious illness or injury, physical assault, homelessness) during the six months prior to
assessment. Psychological distress was assessed using the Brief Symptom Inventory (BSI)
(Derogatis, 1993), which assesses severity—over the prior 7 days—of 53 psychological
distress symptoms; analyses used the Global Severity Index of the BSI, which represents the
average severity of all 53 symptoms.
The independent variable of receipt of additional off-site services used participants’ responses
to a single question—asked during the study’s eligibility screening step that immediately
preceded study enrollment and baseline—about frequency of visits over the prior six months
to any of the following: a physician; psychiatrist, psychologist, or other mental health
professional; social worker; priest, minister, or other spiritual leader; and “some other helping
professional” outside of the MMTP clinic. Although the MMTP clinics have a physician and
nurses on site, service utilization focused on visits to service providers outside of the MMTP
clinics to avoid the confounding effects of visits mandated as part of treatment (i.e., a single,
physical examination by the attending physician upon MMTP enrollment). Responses to the
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receipt of off-site services were collapsed into two categories: 0 = no visit; and 1 = at least 1
visit, herein referred to as “recipients” and “non-recipients” of additional, off-site services
respectively.
For the dependent variables, use of illicit drugs was assessed using the Drug Use and Risk
Behavior Questionnaire (El-Bassel et al., 2000), covering self-reported frequency of crack,
cocaine, heroin, and marijuana use during the 6 months prior to assessment. A participant
scored positive for use of a particular drug if he reported use of that drug in the prior 6 months.
An “any illicit drug use” measure was created collapsing across the individual drug use
categories using the Boolean OR operator. For clarity and ease of comprehension, results in
the final analyses describe (non-)use of drugs: participants who reported no use of a specific
drug were coded as “abstinent” for that specific drug and time period; the attribute for
abstaining from any illicit drug use was calculated by collapsing across abstinence measures
for each drug using the Boolean AND operator. Illicit drug use was assessed during the baseline,
6-month, and 12-month assessment interviews.
2.4 Analyses
This study sought to employ techniques that strengthen the internal validity of findings, i.e.,
minimize potential bias with respect to the effect of receipt of additional, off-site services on
illicit drug use. To that end, several considerations guided the final analysis plan. First, we
sought to account for missing data due to attrition, whose underlying mechanism may lead to
non-ignorable non-response with respect to parameter estimation. Second, since this was a
non-experimental study—i.e., an observational study that lacked random assignment—care
must be taken to ensure that parameter estimates are not biased due to self-selection and other
confounders. Third, analyses receipt of additional, off-site services that preceded illicit drug
use measures in order to establish the correct temporal sequencing of events
Missing data—To minimize the potential for generating biased parameter estimates, as well
as ensuring that calculations account for the uncertainty due to missing observations, we used
multiple imputation (MI) (D. Rubin, 1987; Shafer, 1997) before conducting analyses. In
implementing MI, we created five full (i.e., screening, baseline, 6-month and 12-month follow-
up) datasets in which each instance of a missing value was imputed. In MI, imputed values are
generated by using the information that is observed or measured for a participant in order to
predict values in instances for which that individual’s information is missing. MI relies on
more plausible assumptions than ad hoc imputation methods such as complete-case analysis,
missing value treated as failure, or last-observation carried forward (Little & Rubin, 2002).
Moreover, because MI replaces each missing value with several imputed values, MI effectively
propagates the uncertainty about the missing values, thus leading to more appropriate standard
errors compared to ad hoc and/or single imputation techniques for handling missing data. MI
was performed using multivariate imputation by chained equations (MICE) for Stata (Royston,
2004; van Buuren, Boshuizen, & Knook, 1999).
Propensity score matching—In any non-experimental study, “naïve” attempts (e.g.,
difference in group means) to estimate effects of a predictor variable—in this case, receipt of
additional, off—site services—can result in biased estimates due to selection bias and/or effects
of confounders whose net result is that the group of recipients is not comparable to the non-
recipients of additional, off-site services. Attempting to control for these differences by relying
solely on covariance adjustment in regression equations has been shown to be flawed because
such approaches rely on strong parametric assumptions (for example, linearity), and, when
groups are very dissimilar, may force extrapolations of the model over portions of the covariate
space where there are no data (Dehejia & Wahba, 1999; D. B. Rubin, 1979).
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To address these issues, we employed propensity score matching (Dehejia & Wahba, 1999;
Rosenbaum & Rubin, 1983, 1985) before estimating effects of service utilization on subsequent
illicit drug use. Briefly, propensity scores—formally, the probability that a person belongs to
a group sharing a specific attribute on the predictor variable of interest conditional on attributes
for confounder variables—for each individual are calculated using logistic regression of the
service utilization on the confounding covariates. Separate regression models were created for
each outcome variable, i.e., each specific drug as well as any illicit drug use; in each regression
model, the set of confounder variables included all sociodemographic variables (note:
statistical models used ln(income + $1), an approach widely used in the econometrics literature
(Weichselbaumer & Winter-Ebmer, 2005) and covariates described above, as well as the
attribute for drug use variable reported at baseline. Then, for each participant who reported
receiving additional, off-site services, the participant in the group of non-recipients who has
the closest propensity score is chosen for inclusion in the comparison group (i.e., nearest-
neighbor matching). We used matching with replacement, which tends to yield less biased
estimates than matching without replacement (Dehejia & Wahba, 1998). In these procedures,
unmatched individuals are therefore not included, resulting in a different sample size for each
analysis; from a causal inference perspective, inclusion of data from these non-comparable
individuals in analyses would result in invalid estimates.
Because propensity score matching creates two groups (recipients and non-recipients of
additional, off-site services) who have similar values for observed confounders, this method,
in effect, “reconstructs” a sample that mimics the results of a randomized clinical trial. To
confirm whether the matching has been successful, the covariate distributions should be
compared across the matched groups. For this study we used two tests, the Kolmogorov-
Smirnov and Shapiro-Wilk tests, to confirm that the matching procedures resulted in groups
that were substantially similar on average with respect to confounders and differed only with
respect to the predictor variable of interest.
Estimation of effects—After propensity score matching, we employed binary logistic
regression analyses to test hypotheses regarding the effect of receipt of additional, off-site
services (measured during the study’s first phase) on abstaining from drug use using data
obtained at the 6 month follow-up interview (i.e., during months 0 to 6), the 12-month follow-
up interview (i.e., during months 6 to 12), as well as the combination of the two (i.e., during
the entire 12 month period following assessment of service utilization). Separate regression
models were conducted for each drug as well as any illicit drug use. Each model included
covariance adjustment using the same variables used for propensity score matching. Findings
are presented as adjusted odds ratios (ORs) and their corresponding 95% confidence intervals
(95% CIs).
3. Results
The sociodemographic characteristics of the study sample are presented in Table 1. The
characteristics of this sample are very similar to the overall patient population at the
participating MMTP clinics with respect to age, race/ethnicity, current treatment duration, and
methadone dose (data from clinic records regarding other sociodemographic and health
indicator variables were unavailable to study staff for comparison). Several indicators suggest
a high prevalence of service needs among the sample: almost half (47%) were unemployed;
an average of slightly more than one type stressful life event in the prior six months; an average
level of psychological distress that is more than one standard deviation higher than that
observed in the general population of men in the U.S. (Derogatis, 1993); and an HIV prevalence
of 14%.
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Compared to participants who reported not receiving additional, off-site services, recipients of
such services had significantly more years of education, reported significantly more types of
stressful life events and psychological distress, and were significantly more likely to be HIV-
positive.
With respect to illicit drug use among the study sample, the most frequently reported was
heroin, followed in decreasing order of prevalence by marijuana, cocaine, and then crack.
Overall, about two-thirds of the participants used some type of illicit drugs at the baseline and
6-month follow-up timepoints (66% and 67% respectively), with a lower prevalence at the 12-
month follow-up timepoint (62%). Table 2 provides estimates of the prevalence of illicit drug
use separated by type of illicit drug (and any illicit drug use) and timepoint among the entire
sample as well as subgroups separated by receipt of additional, off-site services.
Table 3 presents estimates of the causal effect (i.e., after propensity score matching and
covariance adjustment for potential confounders) of receipt of additional, off-site services on
the likelihood of abstaining from the indicated drug or any illicit drug use over various ensuing
time periods. Beneficial effects of receipt of additional, off-site services was observed for all
outcome measures during the first six months, with likelihood of abstaining from cocaine,
heroin, and any illicit drug use exceeding the criterion level for significance. During the period
encompassing six to twelve months following receipt of additional, off-site services, point
estimates of the effects of receiving such services were in the beneficial direction all outcome
measures, although only the increase in likelihood of abstaining from any illicit drug use was
significant at the 95% confidence level. With respect to likelihood of abstaining from drug use
during the entire, subsequent 12 month period, recipients of additional, off-site services were
more than two and a half times as likely to abstain from cocaine and heroin use, and more than
three and a half times as likely to abstain from any illicit drug use; estimates for abstaining
from crack and marijuana use were also in the beneficial direction, but did not at the 95%
confidence level.
An eligibility criterion for the parent study required that potential participants current
methadone treatment be at least 3 months. Since the time frame for measuring receipt of
additional, off-site services was assessed at screening and covered a 6 month period, we
examined the extent to which findings might be affected by receipt of additional, off-site
services before initiation of methadone treatment. Only 5 of the participants in this study were
on methadone for 6 months or less: 3 were non-recipients and 2 were recipients of additional
off-site services. Results and inference remain unchanged if the 5 participants who were on
methadone for 6 months or less are withheld from analyses.
Several additional steps were implemented to examine the validity of these findings. First,
balance between the recipients and non-recipients of additional, off-site services after
propensity score matching indicated that the groups were balanced (i.e., not significantly
different) with respect to attributes for variables used for propensity score matching and
covariance adjustment, including variables for which significant differences were observed
before the propensity scoring matching process (e.g., level of education, SLEC score, etc.).
Second, to address the potential problem of non-overlap in propensity scores between
recipients and non-recipients of additional, off-site services, analyses were re-run while
excluding service users whose propensity score fell outside of the range of propensity scores
of non-service users. Third, instead of nearest neighbor matching, we employed caliper
matching using widths that range from ±.02 to ±.10. Sensitivity analyses implementing the
latter two steps indicate that the findings presented in Table 3 remained remarkably consistent.
In some instances, significant findings in Table 3 no longer reached significance at the 95%
confidence level. However, since estimates of the adjusted ORs in those instances changed no
more than 20% (and less than 10% for the vast majority of estimates)—and in no case did the
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point estimate change from the observed beneficial direction (i.e., adjusted OR > 1) to a
detrimental direction (i.e., adjusted OR < 1)—we posit that the essential relationships, and thus
our conclusions, remain unchanged and that the lack of significance observed is due to the
decrease in power stemming from the smaller sample sizes in models that exclude participants
with non-overlapping propensity scores or no matches falling within the caliper width.
4. Discussion
To our knowledge, this is the first study to report the effects of off-site supplemental service
utilization on illicit drug use among men in methadone treatment. Given that this was an
observational study that did not employ random assignment, we have endeavored to employ
methods that maximize the strength and validity of causal inference. Specific steps included:
random sampling to enhance external validity, longitudinal design to establish correct temporal
sequencing of events, multiple imputation minimize bias due to missing data, and propensity
score matching to avoid effects of selection bias (between service users vs. non-service users)
and potential confounder variables. Findings from this study support hypotheses regarding the
positive effects receiving additional, off-site services with respect to increasing the likelihood
of abstaining from illicit drug use in general as well as specifically for cocaine and heroin.
Significant beneficial effects of receiving additional, off-site services were observed not only
in the ensuing 6 months, but also detectable when measuring abstinence over the 12 month
period following supplemental service utilization. During the 6 to 12 month period following
receipt of additional, off-site services, significant effects on engaging in illicit drug use were
only observed when examining any illicit drug use. Failure to observe significant differences
may result from non-recipients subsequently receiving, off-site services during months 0 to 6
—which may lead to a decrease in illicit drug use during months 6 to 12—rather than relapse
among the original group of supplemental service users. We note that all point estimates for
the effects on each individual drug were in the beneficial direction, and thus, our substantive
conclusions regarding the benefits of receipt of additional, off-site services remain unchanged.
Nevertheless, findings from this study substantiate the need for further research to delineate
more definitively whether effects at discrete longer-term periods is simply smaller (and hence
requiring only greater sample size/statistical power to detect significant differences) versus an
alternative scenario in which there is a fundamental change in the relationship between receipt
of additional, off-site services and subsequent likelihood of illicit drug use at discrete, longer-
term follow-up periods.
4.1 Limitations
Before a discussion of the implications from these findings, several limitations are worth
noting. Although prior research has shown that self-reported data about drug use can be reliable
and valid(Darke, 1998; Hser, Maglione, & Boyle, 1999; Johnson et al., 2000), the validity of
drug use measures nonetheless would be strengthened with the use of objective, biological
assays (e.g., urine toxicology). Another limitation stems is the lack of random assignment or
allocation. Propensity score matching represents a state-of-the-art approach to causal inference
using data from an observational study without random assignment to a “treatment” of interest
(i.e., receipt of additional, off-site services), but the causal validity of estimates using
propensity score matching relies on confounders being measured; despite our efforts to include
a comprehensive set of sociodemographic and other proxies/variables (e.g., psychological
distress) for factors drive receipt or non-receipt of additional, off-site services, the possibility
remains that some factor(s) may not have been measured; furthermore, matching over a
collection of multiple variables may still leave imbalance on an individual variable. We note
that such limitations also exist in theory for randomized controlled trials in which there may
be a chance imbalance for both unmeasured and measured variables despite random
assignment. Because receipt of services was not the main focus of the parent study, another
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important limitation stems from the use a crude service utilization measure, prohibiting insight
into important facets of the impact of receipt of additional services, such as the specific nature/
type of services received, “dose” (e.g., number of supplemental service sessions received), and/
or temporal considerations of the receipt of services. Similar concerns can be levied against
the use of dichotomous drug use outcome variables in this study. Nevertheless, despite concerns
about lack of sensitivity due to potentially crude measures, we note that the service measure
used in this study did have predictive power with respect to outcome variables of interest, and
a dichotomous drug use outcome variable corresponds to a clinically meaningful goal of
abstinence. Finally, also due to the focus of the parent study, results can only be generalized
to men on methadone in heterosexual relationships, which represented about half of the
randomly selected men who participated in the screening phase for the parent study.
4.2 Lessons Learned
The aforementioned limitations and associated considerations notwithstanding, this study’s
findings indicate that receipt of additional medical and/or psychosocial services is beneficial
to treatment outcomes focused on abstinence from illicit drug use. These findings also support
and reinforce efforts for drug treatment service providers to address health and psychosocial
needs beyond addiction among their clients. We do not interpret these findings to mean that
on-site provision of services can be replaced by off-site services, especially since earlier
research demonstrates that a greater proportion of clients will receive services when they are
provided on-site (Umbricht-Schneiter et al., 1994). Rather, if provision of such services within
the MMTP is not available or not possible, then methadone treatment service providers may
still find it beneficial to assist patients in receiving such services outside of the MMTP.
Future evaluation and research endeavors should then be designed to collect and analyze data
to address the following: What is the relative cost-effectiveness of on-site versus referral
methods of meeting ancillary needs among drug treatment clients? If on-site provision is not
possible, how can receipt of additional, off-site services be secured or increased? Which types
of additional services or service providers are most helpful and for whom? Is there a minimum
“threshold” (e.g., number of visits within a specific time period) for receipt of additional
services before beneficial effects can be gained? What barriers are encountered when
methadone patients are referred to off-site service providers?
The importance of these efforts are underscored given the high prevalence of service needs
noted among this sample of men in methadone treatment, most of whom are either African
American or Latino. The adverse health conditions (e.g., HIV) prevalent among MMTP
patients are some of the same targets of current federal initiatives designed to eliminate or
reduce health disparities that exist among specific population groups in the United States
(National Institutes of Health, 2001; U.S. Department of Health and Human Services, 2000),
including racial/ethnic minorities as well as disadvantaged socioeconomic groups (e.g., those
without health insurance and/or unemployed). Thus, not only would efforts to increase
supplemental services be likely to improve drug treatment outcomes among methadone
treatment patients, such efforts may represent a valuable venue to address better the public
health system’s goal of reducing or eliminating health disparities in urban settings.
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Table 1
Overview of the study sample, for the total sample as well as by those who received or did not receive additional
off-site services; descriptive statistics are mean (and standard deviation, SD) for continuous variables and number
(and proportion) for categorical variables.
Total sample (N = 356) Recipients (N = 105) Non-recipients (N = 251)
Variable x̄ (SD) x̄ (SD) x̄ (SD)
Age (yrs.) 43.6 (8.5) 43.3 (7.5) 43.8 (9.0)
Yrs. of education 11.6 (2.3) 12.0 (2.3)* 11.5 (2.3)*
Income ($/mo.) 989.2 (957.9) 1066.7 (1143.1) 956.8 (869.4)
Methadone treatment duration (yrs.) 8.3 (7.4) 8.9 (7.6) 8.1 (7.3)
Methadone dose (mg) 84.4 (30.8) 83.5 (29.4) 84.7 (31.3)
SLEC score 1.1 (1.5) 1.8 (2.0)** 0.8 (1.1)**
BSI Global Severity Index 0.6 (0.6) 0.9 (0.7)** 0.5 (0.6)**
n (%) n (%) n (%)
Race/ethnicity
African American 134 (38%) 37 (35%) 97 (39%)
Latino 161 (45%) 44 (42%) 117 (47%)
White/other 61 (17%) 24 (23%) 37 (15%)
Employed 187 (53%) 59 (56%) 128 (51%)
Had health insurance 285 (80%) 90 (86%) 195 (78%)
Marital status
Single, never married 158 (44%) 46 (44%) 112 (45%)
Divorced/separated/widowed 101 (28%) 33 (31%) 68 (27%)
Married 97 (27%) 26 (25%) 71 (28%)
HIV status
Negative 269 (76%) 76 (72%) 193 (77%)
Unknown 36 (10%) 6 (6%) 30 (12%)




p<.01 for differences within a row
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Table 2
Illicit drug use versus time; estimates are proportion (and standard error, SE) of the following groups: the total
sample (N = 356), recipients of additional off-site services (N =105), and non-recipients of additional off-site
services (N = 251).
Months:
0 to 6 6 to 12 0 to 12
Drug Group % (SE) % (SE) % (SE)
Cocaine Total sample 33% (3%) 33% (3%) 31% (3%)
Recipients 28% (4%) 25% (5%) 30% (5%)
Non-recipients 36% (3%) 36% (4%) 32% (3%)
Crack Total sample 19% (2%) 22% (2%) 20% (3%)
Recipients 17% (4%) 25% (5%) 22% (5%)
Non-recipients 20% (3%) 21% (3%) 19% (4%)
Heroin Total sample 51% (3%) 55% (3%) 47% (3%)
Recipients 41% (5%) 50% (5%) 42% (5%)
Non-recipients 55% (3%) 57% (4%) 49% (4%)
Marijuana Total sample 38% (3%) 36% (3%) 38% (4%)
Recipients 37% (5%) 31% (5%) 32% (6%)
Non-recipients 38% (3%) 38% (3%) 40% (4%)
Any illicit drug Total sample 73% (2%) 75% (2%) 71% (3%)
Recipients 66% (5%) 67% (5%) 62% (5%)
Non-recipients 76% (3%) 79% (3%) 75% (3%)
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Table 3
Effects of receiving additional off-site services on likelihood of abstaining from use of indicated drug among
male MMTP patients; estimates are adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) after
propensity score matching and covariance adjustmenta.
After receiving additional off-site services, likelihood of abstaining from indicated drug during months:
0 to 6 6 to 12 0 to 12
Drug N OR [95% CI] OR [95% CI] OR [95% CI]
Cocaine 169 4.76 [1.85, 12.50]*** 1.11 [0.41, 3.03] 2.86 [1.19, 7.14]*
Crack 173 1.10 [0.29, 4.17] 1.59 [0.55, 4.55] 1.56 [0.39, 6.25]
Heroin 172 3.57 [1.47, 9.09]** 1.96 [0.64, 5.88] 2.63 [1.14, 6.25]*
Marijuana 167 1.08 [0.43, 2.70] 1.85 [0.53, 6.67] 1.96 [0.52, 7.69]








Variables used for propensity score matching and covariance adjustment include: age, race/ethnicity, years of formal education, current employment
status, natural log of monthly income, currently having health insurance, marital status, duration of current methadone treatment, current methadone
dose, HIV status, stressful life events (SLEC score), psychological distress (BSI Global Severity Index), and use of indicated drug at time of baseline
assessment.
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